User:Kemorri/sandbox

Draft

 * [1] This source provides information on Spillantini's research fundings and current research targets. It gives an insight into how she's building upon her prior discoveries and continuing her research.
 * In 2022, Spillantini and Tolkovsky gained additional funding from Alzheimer's Research UK for their research concerning dementia. This funding goes towards Spillantini's studies on MMP3, an enzyme whose activity is potentially connected to dementia and other related diseases.
 * [2] This article discusses anle138b, a molecule significant in one of Spillantini's studies. It's a great example of another one of Spillantini's contributions to science and neurodegenerative disease research.
 * Spillantini and her team have also conducted studies on anle138b, a protein that affects clumping of alpha-synuclein. They treated mice with alpha-synuclein clumping- similar to what is seen in Parkinson's disease- with anle138b, and observed a reduction in this clumping.
 * [3] This source lists a significant award won by Spillantini not previously mentioned in the article.
 * [4] This article provides an overview of the quantity of work/studies Spillantini has completed over her career.
 * [5] This article highlights Spillantini's role in minimizing the use of mice in labs thought her tau protein studies, a prominent contribution not currently listed.
 * In 2014, Spillantini and her colleague Aviva Tolkovsky received a NC3Rs Project grant. Following this, they made advances in the way scientists are able to mimic Alzheimer's in mice, minimizing the amount of mice necessary.
 * [6] This source mentions the possibility of Spillantini's work leading to the discovery of potential therapeutic targets.
 * Spillantini's research has led to a greater understanding of a variety of neurodegenerative diseases, and has created new possibilities for therapies that target these diseases.
 * [7] This source provides a list of awards won by Spillantini, some of which are currently missing from the article.
 * Spillantini has upwards of 240 publications in the field of neuroscience.